CFDE Data Portal | Search GVINP1

	Label	Description
	GVINP1 Gene (Entity type)	ENSG00000254838 - GTPase, very large interferon inducible pseudogene 1
	GVINP1 associations Collection (Entity type)	Associations for GVINP1_associations
	GVINP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	T62-Spleen Consensus Gene Set (Entity type)	A Gene Set from MoTrPAC
	GSE172219 adenosine 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS

GVINP1

ENSG00000254838 - GTPase, very large interferon inducible pseudogene 1

GVINP1 associations

Associations for GVINP1_associations

GVINP1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE169617 azacitidine 1 v 2 human up

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

T62-Spleen Consensus

A Gene Set from MoTrPAC

GSE172219 adenosine 2 v 1 human dn

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 3 v 6 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 3 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 11 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.